Showing 2491-2500 of 21408 results for "".
- Acute Ischemic Stroke Care at a Crossroads: Endovascular Thrombectomy Meets Emerging Pharmacological Adjunctshttps://reachmd.com/news/acute-ischemic-stroke-care-at-a-crossroads-endovascular-thrombectomy-meets-emerging-pharmacological-adjuncts/2474863/Acute ischemic stroke care is at a crossroads: while endovascular thrombectomy has become the cornerstone of large‐vessel occlusion intervention, emerging pharmacological adjuncts promise to shift the balance toward improved neurological reco
- AI-Enhanced 3D Virtual Staining: The Future of Non-Invasive Cancer Diagnosticshttps://reachmd.com/news/ai-enhanced-3d-virtual-staining-the-future-of-non-invasive-cancer-diagnostics/2474860/Rapid advances in AI-enhanced imaging are redefining cancer diagnostics, and 3D virtual staining offers clinicians detailed insights into tumor biology. However, it is important to acknowledge that the technology is still undergoing validatio
- Advancing Cancer Immunotherapy with Rheumatology: Modern Screening and Diagnostic Innovationshttps://reachmd.com/news/advancing-cancer-immunotherapy-with-rheumatology-modern-screening-and-diagnostic-innovations/2474848/As cancer immunotherapy progresses, it introduces new challenges in managing rheumatic adverse effects, demanding innovative screening and diagnostic strategies that bridge oncology and rheumatology. Immune checkpoint inhibitors and ot
- Emerging Techniques in Postoperative Pain Management: Prolactin Inhibition for Womenhttps://reachmd.com/news/emerging-techniques-in-postoperative-pain-management-prolactin-inhibition-for-women/2474839/Hormonal influences, notably prolactin released under preoperative stress, are reshaping postoperative pain management for women and demanding fresh strategies beyond traditional analgesia. Postoperative pain relief in women has long c
- Integrating Phytomedicine and Nanotechnology in Managing COVID-19 Related Acute Coronary Syndromehttps://reachmd.com/news/integrating-phytomedicine-and-nanotechnology-in-managing-covid-19-related-acute-coronary-syndrome/2474828/COVID-19 initiates a robust inflammatory response capable of precipitating severe cardiovascular events, notably acute coronary syndrome. The linkage between viral infection and cardiovascular pathology necessitates innovative treatment strategies. Preclinic
- Geriatric Polypharmacy: Balancing Medication Interactions and Inappropriate Prescribinghttps://reachmd.com/news/geriatric-polypharmacy-balancing-medication-interactions-and-inappropriate-prescribing/2474827/Investigations have pinpointed critical prescribing thresholds and high-risk medication combinations in geriatric care. This awareness aids in customizing treatment plans to individual needs, thereby reducing adverse outcomes. Our insights stress the importance of
- Optimizing AI for Fracture Detection: Addressing Blind Spots and Enhancing Imaging Accuracyhttps://reachmd.com/news/optimizing-ai-for-fracture-detection-addressing-blind-spots-and-enhancing-imaging-accuracy/2474819/By automating tasks such as image segmentation and anomaly detection, AI is essential in standardizing radiograph evaluations and accelerating treatment decisions. These advancements have a significant impact: improving detection accuracy and drastically reducing d
- Radiation Protection and Imaging: [89Zr]Zr-girentuximab PET in Surgical Settingshttps://reachmd.com/news/radiation-protection-and-imaging-89zrzr-girentuximab-pet-in-surgical-settings/2474820/The convergence of [89Zr]Zr-girentuximab PET imaging with stringent radiation safety measures marks a significant advancement. This innovative approach elevates diagnostic image quality while bolstering surgical outcomes. Harness
- Cutaneous Immune-Related Adverse Events: Indicators of Systemic Toxicities and Survival in Melanomahttps://reachmd.com/news/cutaneous-immune-related-adverse-events-indicators-of-systemic-toxicities-and-survival-in-melanoma/2474813/Cutaneous immune-related adverse events (cIRAEs) in melanoma patients undergoing immune checkpoint inhibitor therapy present a clinical paradox. While these skin toxicities indicate an increased risk of multisystem adverse events—including gastrointestinal, ocular, endocrin
- Experimental Drug and Its Impact on Slowing Rare ALS Progressionhttps://reachmd.com/news/experimental-drug-and-its-impact-on-slowing-rare-als-progression/2474812/Recent clinical trials examining an innovative drug for a rare ALS form present hopeful evidence in slowing the swift progression typical of this devastating condition. The experimental therapy shows potential in decelerating rare ALS progress, opening